DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Mosella MS, Sabedot TS, Silva TC, Malta TM, et al. Neuro Oncol 2021;23:1292-1303.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mosella MS, Sabedot TS, Silva TC, Malta TM, et al. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro Oncol 2021;23:1292-1303.
PMID: 33631002